These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27160570)

  • 1. Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy.
    Owens E; Krecke K; Ahlskog JE; Fealey R; Hassan A; Josephs KA; Klassen B; Matsumoto J; Bower J
    Parkinsonism Relat Disord; 2016 Jul; 28():107-11. PubMed ID: 27160570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic.
    Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E
    Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.
    Kaasinen V; Kangassalo N; Gardberg M; Isotalo J; Karhu J; Parkkola R; Sonninen P
    Neurol Sci; 2015 Jul; 36(7):1251-3. PubMed ID: 25805708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.
    Mueller C; Hussl A; Krismer F; Heim B; Mahlknecht P; Nocker M; Scherfler C; Mair K; Esterhammer R; Schocke M; Wenning GK; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Sep; 54():90-94. PubMed ID: 29643007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDS criteria for the diagnosis of progressive supranuclear palsy overemphasize Richardson syndrome.
    Frank A; Peikert K; Linn J; Brandt MD; Hermann A
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1702-1707. PubMed ID: 32735745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "One line": A method for differential diagnosis of parkinsonian syndromes.
    Sako W; Abe T; Haji S; Murakami N; Osaki Y; Izumi Y; Harada M; Kaji R
    Acta Neurol Scand; 2019 Sep; 140(3):229-235. PubMed ID: 31225648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.
    Massey LA; Jäger HR; Paviour DC; O'Sullivan SS; Ling H; Williams DR; Kallis C; Holton J; Revesz T; Burn DJ; Yousry T; Lees AJ; Fox NC; Micallef C
    Neurology; 2013 May; 80(20):1856-61. PubMed ID: 23616165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting.
    Cooperrider J; Bluett B; Jones SE
    Clin Park Relat Disord; 2020; 3():100033. PubMed ID: 34316619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2017 Jul; 378():153-157. PubMed ID: 28566154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.